Clarifying the use of erythropoietic agents.
作者信息
Smith Robert E
出版信息
J Support Oncol. 2004 May-Jun;2(3):200, 202; author reply 202.
PMID:15328822
Abstract
摘要
相似文献
1
Clarifying the use of erythropoietic agents.明确促红细胞生成剂的使用方法。
J Support Oncol. 2004 May-Jun;2(3):200, 202; author reply 202.
2
New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony.美国血液学会/美国临床肿瘤学会关于促红细胞生成素类药物使用的新指南：噪音中的合唱曲。
J Support Oncol. 2007 Nov-Dec;5(10):471-3.
3
Utilizing quality of life as a factor in treatment choices for chemotherapy-induced anemia.
J Support Oncol. 2005 Nov-Dec;3(6 Suppl 4):20-1.
4
Earlier initiation of treatment recommended in using erythropoietic agents for chemotherapy-induced anemia.对于化疗所致贫血使用促红细胞生成剂时，建议更早开始治疗。
J Support Oncol. 2004 Jul-Aug;2(4):319.
5
[Use of erythropoietin in the treatment of cancer-related anemia].促红细胞生成素在癌症相关性贫血治疗中的应用
Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):877-8.
6
Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.促红细胞生成素：按指示使用时安全性良好。
Strahlenther Onkol. 2008 Mar;184(3):121-36. doi: 10.1007/s00066-008-1841-3.
7
Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy.接受骨髓抑制性化疗的贫血癌症患儿的血红蛋白反应及生活质量改善情况
J Support Oncol. 2005 Nov-Dec;3(6 Suppl 4):10-1.
8
Comparative studies on erythropoietic agents.
J Natl Compr Canc Netw. 2005 Nov;3 Suppl 1:S46-9.
9
Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.β-促红细胞生成素每周一次：化疗所致贫血患者疗效与安全性综述
Expert Rev Anticancer Ther. 2008 Jun;8(6):875-85. doi: 10.1586/14737140.8.6.875.
10
Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.
Clin Drug Investig. 2007;27(9):661-2. doi: 10.2165/00044011-200727090-00007.
Zotero 插件